Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

577.85 +35.96 (+6.64%)
Delayed Quote Updated: 12:52 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
From United Therapeutics Corporation
Via Business Wire
News headline image
Bullet Proof Your Portfolio: 3 Must-Have Defensive Stocks for 2023 ↗
Defensive stocks have always been the go-to investments for those looking to protect their long-term portfolio and weather downturns. 
Via InvestorPlace
News headline image
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics: A Strong Quarter But What About 2024? ↗
United Therapeutics had strong Tyvaso sales but it highlights the investor debate heading into 2024. 
Via Talk Markets
News headline image
What 4 Analyst Ratings Have To Say About United Therapeutics ↗
 
Via Benzinga
News headline image
United Therapeutics's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors. 
Via InvestorPlace
News headline image
United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
From United Therapeutics Corporation
Via Business Wire
News headline image
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names ↗
These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire. 
Via InvestorPlace
News headline image
United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
The Latest Analyst Ratings for United Therapeutics ↗
 
Via Benzinga
News headline image
Why United Therapeutics Shares Are Falling Today ↗
United Therapeutics Corporation's (NASDAQ: UTHR) Q1 revenues grew 10% Y/Y to $506.9 million, missing the  
Via Benzinga
News headline image
United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Unveils Net Zero Energy Distribution Center
From United Therapeutics Corporation
Via Business Wire
News headline image
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside. 
Via MarketBeat
News headline image
Recap: United Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
Analyst Expectations for United Therapeutics's Future ↗
 
Via Benzinga
News headline image
This Foreboding Sign Looms Over United Therapeutics's Chart ↗
 
Via Benzinga
News headline image
Earnings Outlook For United Therapeutics ↗
 
Via Benzinga
News headline image
United Therapeutics Corporation Reports First Quarter 2023 Financial Results
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
7 Biotech Stocks That Could Cure Your Portfolio Woes ↗
If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill. 
Via InvestorPlace
News headline image
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
Earnings Scheduled For February 22, 2023 ↗
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.